GlassScriptPhysician profile
Sara Goel
NPI 1023244431
$14,580.89
in general payments reported to CMS, 2019-2025
45 companies · $2,915 in 2025
The $2,915 reported for 2025 was more than what 90% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,595 · 2020: $2,192 · 2021: $1,917 · 2022: $1,194 · 2023: $2,131 · 2024: $1,638 · 2025: $2,915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,490 · Travel and Lodging: $1,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,489.80 |
| Travel and Lodging | $1,193.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,834.20 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Boston Scientific Corporation | $2,226.31 | 2019-2024 | Infinion 16 |
| Nevro Corp. | $2,100.98 | 2019-2024 | Senza |
| Spr Therapeutics, INC | $1,695.80 | 2023-2025 | Sprint Pns System |
| Relievant Medsystems, INC. | $778.17 | 2020-2023 | Intracept |
| Medtronic USA, INC. | $552.75 | 2019-2020 | |
| Abbott Laboratories | $521.15 | 2019-2025 | Proclaim |
| Collegium Pharmaceutical, INC. | $375.52 | 2019-2025 | Belbuca, Xtampza |
| Abbvie INC. | $367.95 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $317.78 | 2019-2025 | Relistor |
| Si-Bone, INC. | $299.66 | 2020-2025 | |
| Nalu Medical, INC. | $276.92 | 2022-2025 | Nalu Neurostimulation System |
| Stryker Corporation | $259.34 | 2019-2023 | Optablate, Omnicurve, Spinejack |
| Epimed International, INC | $188.12 | 2021-2022 | |
| Lundbeck LLC | $175.49 | 2023 | Vyepti |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Goel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.